Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial

Joseph F. Largay, Ajay Sood, Hertzel C. Gerstein, Matthew C. Riddle, Faramarz Ismail-Beigi, David J. Brillon, Debra L. Simmons, Irene Hramiak, Richard M. Bergenstal, Zubin Punthakee, Michael E. Miller, Peter J. Savage
We aimed to determine the persistence of glycaemic control 1 year after a limited period of intensive glycaemic management of type 2 diabetes.
doi:10.17615/445x-d388 fatcat:pcwfe3qyhretrb27ygsagc5com